Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 33 citing Harrison: Pancreatic β-cell function and immune responses to insulin after administration.... (0.09 sec) 

A comprehensive review of interventions in the NOD mouse and implications for translation

- cell.com
LKM Shoda, DL Young, S Ramanujan, CC … - Immunity, 2005 - Elsevier
Type 1 diabetes (T1D) animal models such as the nonobese diabetic (NOD) mouse
have improved our understanding of disease pathophysiology, but many candidate
therapeutics identified therein have failed to prevent/cure human disease. ...
Cited by 94 - Related articles - All 6 versions

Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches …


T Staeva-Vieira, M Peakman, M Von Herrath - Clinical and Experimental Immunology, 2007 - pubmedcentral.nih.gov
Type 1 diabetes (T1D) is often considered the prototype organ-specific
autoimmune disease in clinical immunology circles. The key disease features −
precise destruction of a single endocrine cell type occurring on a distinct ...
Cited by 47 - Related articles - BL Direct - All 5 versions

Immunotherapy for the prevention and treatment of type 1 diabetes


KS Goudy, R Tisch - International reviews of immunology, 2005 - informahealthcare.com
A major effort has been on-going to develop immunotherapies to prevent and/or
treat type 1 diabetes (T1D). This autoimmune disease is characterized by the
selective loss of the insulin-producing β cells via the cumulative effects ...
Cited by 25 - Related articles - BL Direct - All 5 versions

Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of …


S You, N Thieblemont, MA Alyanakian, JF … - Immunol Rev, 2006 - interscience.wiley.com
Summary: It is now well‐established that CD4 + regulatory T cells are
instrumental in controlling immune responses both to self‐antigens and to
non‐self‐antigens. However, the precise modalities involved in their ...
Cited by 25 - Related articles - BL Direct - All 5 versions

Moving towards efficient therapies in type 1 diabetes: To combine or not to combine?

- nih.gov
D Bresson, M Von Herrath - Autoimmunity reviews, 2007 - Elsevier
Every year, thirty thousand people worldwide are diagnosed with type 1 diabetes
mellitus (T1DM). T1DM, also called autoimmune diabetes, is a multifactorial
disease affecting predisposed individuals and involving genetic ...
Cited by 20 - Related articles - All 3 versions

Type 1 diabetes intervention trials 2007: where are we and where are we going?


MJ Haller, PA Gottlieb, DA Schatz - Current Opinion in Endocrinology, Diabetes and …, 2007 - journals.lww.com
Purpose of review: Type 1 diabetes (T1D) is characterized by autoimmune-mediated
destruction of pancreatic β cells culminating in absolute insulin deficiency.
Despite enhanced knowledge of the natural history of type 1 diabetes we ...
Cited by 10 - Related articles - BL Direct - All 2 versions

Managing psychiatric disorders with antidiabetic agents: translational research and …


RS McIntyre, JK Soczynska, GF Lewis, GM … - Expert Opin. Pharmacother., 2006 - Informa Pharma Science
The objective of this paper is to synthesise extant studies describing the
neurotherapeutic effects of antidiabetic agents in neuropsychiatric disorders.
The authors conducted a MedLine search of all English-language articles ...
Cited by 7 - Related articles - BL Direct - All 5 versions

Immunology of type 1 diabetes

- oxfordjournals.org
P Narendran, E Estella, S Fourlanos - Qjm, 2005 - Oxford Univ Press
There are over one million islets in a healthy adult pancreas. They make up 1%
of the total pancreatic volume, weigh about 1 g, and contain about 1 mg of
insulin. 4 Histological analysis of the pancreas from patients with type 1 ...
Cited by 7 - Related articles - BL Direct - All 7 versions

Immunological responses to exogenous insulin

- endojournals.org
SE Fineberg, TT Kawabata, D Finco-Kent, RJ … - Endocrine Reviews, 2007 - Endocrine Soc
Regardless of purity and origin, therapeutic insulins continue to be immunogenic
in humans. However, severe immunological complications occur rarely, and less
severe events affect a small minority of patients. Insulin autoantibodies ...
Cited by 6 - Related articles - BL Direct - All 3 versions

Vaccination against self to prevent autoimmune disease: the type 1 diabetes model


LC Harrison - Immunology and Cell Biology, 2008 - nature.com
Immune tolerance to self-antigens is physiological. Given a repertoire of
self-reactive, potentially pathogenic lymphocytes, therapeutic options to
diminish autoimmune disease risk include deletion, reduced activation or ...
Cited by 6 - Related articles - All 4 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google